These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 35714911)

  • 21. Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma.
    von Roemeling CA; Copland JA
    Expert Opin Ther Targets; 2016; 20(2):159-66. PubMed ID: 26414044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
    Ray U; Roy SS
    FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications.
    Zeković M; Bumbaširević U; Živković M; Pejčić T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid metabolism and lipophagy in cancer.
    Maan M; Peters JM; Dutta M; Patterson AD
    Biochem Biophys Res Commun; 2018 Oct; 504(3):582-589. PubMed ID: 29438712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Intra- and Extracellular Lipid Signals in Cancer Stemness and Potential Therapeutic Strategy.
    Hu J; Zhang L; Chen W; Shen L; Jiang J; Sun S; Chen Z
    Front Pharmacol; 2021; 12():730751. PubMed ID: 34603046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression.
    Zhou J; Zhao J; Su C
    Curr Cancer Drug Targets; 2021; 21(8):631-639. PubMed ID: 33726650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid metabolism in focus: how the build-up and breakdown of lipids affects stem cells.
    Madsen S; Ramosaj M; Knobloch M
    Development; 2021 May; 148(10):. PubMed ID: 34042969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
    Vishwa R; BharathwajChetty B; Girisa S; Aswani BS; Alqahtani MS; Abbas M; Hegde M; Kunnumakkara AB
    Cancer Metastasis Rev; 2024 Mar; 43(1):293-319. PubMed ID: 38438800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid Metabolism and Mitochondria: Cross Talk in Cancer.
    Srivastava A; Srivastava P; Mathur S; Abbas S; Rai N; Tiwari S; Tiwari M; Sharma L
    Curr Drug Targets; 2022; 23(6):606-627. PubMed ID: 34431462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.
    Menendez JA
    Biochim Biophys Acta; 2010 Mar; 1801(3):381-91. PubMed ID: 19782152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment.
    Zuo Q; Wu Y; Hu Y; Shao C; Liang Y; Chen L; Guo Q; Huang P; Chen Q
    Heliyon; 2024 May; 10(9):e30807. PubMed ID: 38765144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging targets in lipid metabolism for cancer therapy.
    Terry AR; Hay N
    Trends Pharmacol Sci; 2024 Jun; 45(6):537-551. PubMed ID: 38762377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.
    Wang J; Zhang W; Liu C; Wang L; Wu J; Sun C; Wu Q
    Int J Biol Sci; 2024; 20(5):1884-1904. PubMed ID: 38481820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty acid oxidation: An emerging facet of metabolic transformation in cancer.
    Ma Y; Temkin SM; Hawkridge AM; Guo C; Wang W; Wang XY; Fang X
    Cancer Lett; 2018 Oct; 435():92-100. PubMed ID: 30102953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
    Hu B; Lin JZ; Yang XB; Sang XT
    Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism.
    Gómez de Cedrón M; Ramírez de Molina A
    J Lipid Res; 2016 Feb; 57(2):193-206. PubMed ID: 26630911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttranslational control of lipogenesis in the tumor microenvironment.
    Zhu Y; Lin X; Zhou X; Prochownik EV; Wang F; Li Y
    J Hematol Oncol; 2022 Aug; 15(1):120. PubMed ID: 36038892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications.
    Yoon H; Lee S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid metabolism in cancer progression and therapeutic strategies.
    Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
    MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.